CALGB90202_2B | R Documentation |
Kaplan-Meier digitized data from CALGB90202, figure 2B (PMID 24590644). A reported sample size of 645 for a primary endpoint of time_SRE in prostate cancer.
CALGB90202_2B
A data frame of 645 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (placebo, za) | |
Smith MR, Halabi S, Ryan CJ, et al. Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance). J Clin Oncol 2014; 32: 1143–50.
summary(CALGB90202_2B)
kmplot(CALGB90202_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.